Skip to main content

Featured

New Tensions Rise as Iran Warns of Possible Strikes on Regional Energy Sites

  Iran has issued a sharp warning that it may target regional energy infrastructure following recent threats from U.S. President Donald Trump over the Strait of Hormuz. The exchange marks a renewed escalation in a long‑running standoff over one of the world’s most critical maritime chokepoints. According to Iranian officials, any attempt to restrict Tehran’s access to the strait would be met with what they described as “direct and proportional” action. Energy facilities across the Gulf—central to global oil and gas supply—were specifically mentioned as potential targets if tensions continue to rise. The Trump administration has repeatedly criticized Iran’s activities in the region, warning of consequences should Tehran interfere with international shipping. The latest remarks from Washington prompted Iran’s response, which framed its position as defensive and tied to national sovereignty. Regional governments have expressed concern that even rhetorical escalation could unsettle...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment